Early P2Y<sub>12</sub> Inhibitor Single Antiplatelet Therapy for High-Bleeding Risk Patients After Stenting　― PENDULUM Mono 24-Month Analysis ―-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Early P2Y<sub>12</sub> Inhibitor Single Antiplatelet Therapy for High-Bleeding Risk Patients After Stenting　― PENDULUM Mono 24-Month Analysis ―

Published:2022-08-25 Issue:9 Volume:86 Page:1352-1361
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Nakagawa Yoshihisa¹,Kadota Kazushige²,Nakao Koichi³,Shite Junya⁴,Yokoi Hiroyoshi⁵,Kozuma Ken⁶,Tanabe Kengo⁷,Akasaka Takashi⁸,Shinke Toshiro⁹,Ueno Takafumi¹⁰,Hirayama Atsushi¹¹,Uemura Shiro¹²,Iijima Raisuke¹³,Harada Atsushi¹⁴,Kuroda Takeshi¹⁵,Takita Atsushi¹⁶,Murakami Yoshitaka¹⁷,Saito Shigeru¹⁸,Nakamura Masato¹³

Affiliation:

1. Department of Cardiovascular Medicine, Shiga University of Medical Science

2. Department of Cardiology, Kurashiki Central Hospital

3. Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center

4. Division of Cardiology, Osaka Saiseikai Nakatsu Hospital

5. Cardiovascular Medicine Center, Fukuoka Sanno Hospital

6. Division of Cardiology, Department of Internal Medicine, Teikyo University

7. Division of Cardiology, Mitsui Memorial Hospital

8. Department of Cardiovascular Medicine, Wakayama Medical University

9. Division of Cardiology, Department of Medicine, Showa University School of Medicine

10. Department of Cardiovascular Medicine, Fukuoka Kinen Hospital

11. Department of Cardiology, Osaka Police Hospital

12. Department of Cardiology, Kawasaki Medical School

13. Division of Cardiovascular Medicine, Toho University Ohashi Medical Center

14. Medical Information Department, Daiichi Sankyo Co., Ltd

15. Primary Medical Science Department, Daiichi Sankyo Co., Ltd

16. Data Intelligence Department, Daiichi Sankyo Co., Ltd

17. Department of Medical Statistics, School of Medicine, Toho University

18. Division of Cardiology and Catheterization Laboratories, Shonan Kamakura General Hospital

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/86/9/86_CJ-21-1004/_pdf

Reference20 articles.

1. 1. Leon MB, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KK, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting: Stent Anticoagulation Restenosis Study Investigators. N Engl J Med 1998; 339: 1665–1671.

2. 2. Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, et al. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 2014; 371: 2155–2166.

3. 3. Palmerini T, Benedetto U, Bacchi-Reggiani L, Della Riva D, Biondi-Zoccai G, Feres F, et al. Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: A pairwise and Bayesian network meta-analysis of randomized trials. Lancet 2015; 385: 2371–2382.

4. 4. Toyota T, Shiomi H, Morimoto T, Natsuaki M, Kimura T. Short versus prolonged dual antiplatelet therapy (DAPT) duration after coronary stent implantation: A comparison between the DAPT study and 9 other trials evaluating DAPT duration. PLoS One 2017; 12: e0174502.

5. 5. Nakamura M, Kimura K, Kimura T, Ishihara M, Otsuka F, Kozuma K, et al. JCS 2020 guideline focused update on antithrombotic therapy in patients with coronary artery disease. Circ J 2020; 84: 831–865.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genotype-Guided Antiplatelet Therapy After Coronary Intervention in Patients With High Bleeding Risk　― Never Judge a Book by Its Cover ―;Circulation Journal;2023-05-25

2. Clopidogrel Use in <i>CYP2C19</i> Loss-of-Function Carriers With High Bleeding Risk After Percutaneous Coronary Intervention;Circulation Journal;2023-05-25

3. How Can We Prevent Both Bleeding and Ischemic Events After Percutaneous Coronary Intervention in High-Bleeding Risk Patients?;Circulation Journal;2022-08-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3